UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054382
Receipt number R000062112
Scientific Title Empirical study on confirmation and evaluation of temperature changes in the menstrual cycle (biphasic) using wearable devices capable of continuous temperature measurement (developed products) -Verification of reliability, validity, and clinical usefulness of confirmation and evaluation of temperature changes (biphasic) in the menstrual cycle-
Date of disclosure of the study information 2024/06/07
Last modified on 2024/11/13 12:01:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Empirical study on confirmation and evaluation of temperature changes in the menstrual cycle (biphasic) using wearable devices capable of continuous temperature measurement (developed products)
-Verification of reliability, validity, and clinical usefulness of confirmation and evaluation of temperature changes (biphasic) in the menstrual cycle-

Acronym

Empirical study on confirmation of temperature changes in the menstrual cycle (biphasic) using wearable devices (developed products)

Scientific Title

Empirical study on confirmation and evaluation of temperature changes in the menstrual cycle (biphasic) using wearable devices capable of continuous temperature measurement (developed products)
-Verification of reliability, validity, and clinical usefulness of confirmation and evaluation of temperature changes (biphasic) in the menstrual cycle-

Scientific Title:Acronym

Empirical study on confirmation of temperature changes in the menstrual cycle (biphasic) using wearable devices (developed products)

Region

Japan


Condition

Condition

Female with menstrual cycle

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to demonstrate that the data continuously measured during sleep using the developed wearable device (hereinafter referred to as abdominal temperature) can capture biphasic temperature changes associated with the menstrual cycle, similar to the data measured in the mouth with a conventional women's thermometer at the time of waking up (hereinafter referred to as "mouth temperature"). The purpose of this service is to predict the ovulation period and the next menstrual cycle from the analysis results of measurement data, and to provide users with prediction of premenstrual syndrome based on understanding the correct menstrual cycle.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Confirmation of the feasibility of using abdominal temperature as a method of biphasic confirmation of the menstrual cycle

Key secondary outcomes

(1) Number of days in the high-temperature phase determined from the point of change in abdominal temperature and mouth temperature
(2) Correlation coefficient between the typical temperature of the day and the temperature of the mouth
(3) Validity as a continuous measurement method
(4) Verification of the accuracy of the menstrual cycle prediction model


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

54 years-old >=

Gender

Female

Key inclusion criteria

Women with a stable menstrual cycle in the last 3 cycles (28-35 day cycles)

Key exclusion criteria

1. Those who are currently attending a gynecological clinic and are undergoing treatment, those who have a history of uterine or ovarian surgery, and those who have a history or current infection of gynecological malignancies such as uterine cancer, ovarian cancer, and breast cancer
2. Those who take oral contraceptives such as pills or other female hormones
3. Those who are unable to participate due to physical or mental health reasons at the discretion of a physician
4. Persons who are unable to obtain consent due to personal circumstances, etc.
5. Those who are judged by the principal investigator to be inappropriate as the subject of this study
6. Those who are unable to communicate in Japanese
7. Those who are unable to connect to their own WIFI when sleeping, in an environment where 4G or 5G communication is not possible
8. Those who are pregnant
9. Those who are likely to become pregnant during the course (excluding sudden ones) * However, if it is found that you are pregnant during participation, you can continue
10. Those who are planning to travel or on a business trip and have to change their sleeping place (excluding sudden ones)
11. Those who work the night shift

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Asako
Middle name
Last name Taniuchi

Organization

EMICLE CLINIC

Division name

EMICLE CLINIC

Zip code

420-0033

Address

2F Sanko Bldg. 3-6 Showa-cho, Aoi-ku, Shizuoka city, Shizuoka, 420-0033, Japan

TEL

054-204-1186

Email

a_taniuchi@marianna-u.ac.jp


Public contact

Name of contact person

1st name Kazuma
Middle name
Last name Toda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place 5F, 5-27-1 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

toda.kazuma@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Murata Manufacturing Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

35

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 04 Month 11 Day

Date of IRB

2024 Year 04 Month 11 Day

Anticipated trial start date

2024 Year 06 Month 08 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, with the cooperation of healthy women with menstrual cycles, abdominal temperature (temperature calculated using an existing algorithm built at Murata Manufacturing Co., Ltd. based on the temperature inside the clothes and the temperature inside the clothing: hereinafter referred to as the abdominal temperature) and the temperature in the mouth were collected in parallel for three cycles, and the correlation between each variable and the point of change between the two phases were evaluated by statistical analysis. In addition, the physical and mental situation is collected in the form of a daily questionnaire. Using these data, we will construct a menstrual cycle prediction model.


Management information

Registered date

2024 Year 05 Month 13 Day

Last modified on

2024 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062112